Chrystal Louis, M.D., M.P.H.

Chrystal Louis, M.D., M.P.H.

Chief Medical OfficeratTScan Therapeutics· In proxies 2024–2025

Pay in FY2024TScan Therapeutics stock -47.9% the same year

Chrystal Louis, M.D., M.P.H. was paid $3.0M in FY2024 (Dec). TScan Therapeutics stock fell 47.9% that year.

Pay$100 in the stock at the end of FY23 → $52
Pay is from the Summary Compensation Table of each TScan Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. TScan TherapeuticsPublic company · 2 yr
    • Chief Medical Officer2024 – Present · 2 yrStock in role -97%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?